Effect of reactive oxygen species overproduction on osteogenesis of porous titanium implant in the present of diabetes mellitus

Biomaterials

Volumn 34, Issue 9, 2013, Pages 2234-2243

  Feng, Ya Fei ^a   Wang, Lin ^a   Zhang, Yang ^a   Li, Xiang ^b   Ma, Zhen Sheng ^a   Zou, Ji Wei ^a   Lei, Wei ^a   Zhang, Zhi Yong ^c,d  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d National Tissue Engineering Center of China   (China)

Author keywords

Antioxidant; Bone defect; Diabetes; Osteogenesis; Porous titanium; Reactive oxygen species

Indexed keywords

ANTIOXIDANT; BONE DEFECT; OSTEOGENESIS; POROUS TITANIUM; REACTIVE OXYGEN SPECIES;

BODY FLUIDS; BONE; CELL DEATH; CELL PROLIFERATION; MEDICAL PROBLEMS; OSTEOBLASTS; OXYGEN; TITANIUM;

PATIENT TREATMENT;

REACTIVE OXYGEN METABOLITE; TITANIUM;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE DEFECT; BONE DEVELOPMENT; BONE IMPLANT; CONTROLLED STUDY; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMUR CONDYLE; IN VIVO STUDY; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL;

ALKALINE PHOSPHATASE; ANIMALS; APOPTOSIS; CASPASE 3; CELL PROLIFERATION; DIABETES MELLITUS; HYDROGEN PEROXIDE; MALE; MITOCHONDRIA; OSTEOBLASTS; OSTEOGENESIS; OXIDATIVE STRESS; POROSITY; PROSTHESES AND IMPLANTS; RABBITS; REACTIVE OXYGEN SPECIES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TITANIUM;

ORYCTOLAGUS CUNICULUS;

EID: 84872385285     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.12.023     Document Type: Article

References (51)

1. Costantino P.D., Friedman C.D., Lane A. Synthetic biomaterials in facial plastic and reconstructive surgery. Facial Plast Surg 1993, 9:1-15.
2. Niinomi M. Metallic biomaterials. J Artif Organs 2008, 11:105-110.
3. Guillemot F. Recent advances in the design of titanium alloys for orthopedic applications. Expert Rev Med Devices 2005, 2:741-748.
4. Niinomi M. Mechanical biocompatibilities of titanium alloys for biomedical applications. J Mech Behav Biomed Mater 2008, 1:30-42.
5. Javed F., Romanos G.E. Impact of diabetes mellitus and glycemic control on the osseointegration of dental implants: a systematic literature review. J Periodontol 2009, 80:1719-1730.
6. Prisby R.D., Swift J.M., Bloomfield S.A., Hogan H.A., Delp M.D. Altered bone mass, geometry and mechanical properties during the development and progression of type 2 diabetes in the Zucker diabetic fatty rat. J Endocrinol 2008, 199:379-388.
7. Yu M., Zhou W., Song Y., Yu F., Li D., Na S., et al. Development of mesenchymal stem cell-implant complexes by cultured cells sheet enhances osseointegration in type 2 diabetic rat model. Bone 2011, 49:387-394.
8. Giacco F., Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010, 107:1058-1070.
9. Wei W., Liu Q., Tan Y., Liu L., Li X., Cai L. Oxidative stress, diabetes, and diabetic complications. Hemoglobin 2009, 33:370-377.
10. Hoetzenecker W., Echtenacher B., Guenova E., Hoetzenecker K., Woelbing F., Bruck J., et al. ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression. Nat Med 2012, 18:128-134.
11. Sedeek M., Callera G., Montezano A., Gutsol A., Heitz F., Szyndralewiez C., et al. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. Am J Physiol Ren Physiol 2010, 299:F1348-F1358.
12. Wang X., Gu C., He W., Ye X., Chen H., Zhang X., et al. Glucose oxidase induces insulin resistance via influencing multiple targets in vitro and in vivo: the central role of oxidative stress. Biochimie 2012, 94:1705-1717.
13. Di Naso F.C., Rodrigues G., Dias A.S., Porawski M., Fillmann H., Marroni N.P. Hepatic nitrosative stress in experimental diabetes. J Diabetes Complications 2012, 26:378-381.
14. Lopez-Heredia M.A., Sohier J., Gaillard C., Quillard S., Dorget M., Layrolle P. Rapid prototyped porous titanium coated with calcium phosphate as a scaffold for bone tissue engineering. Biomaterials 2008, 29:2608-2615.
15. Hollander D.A., von Walter M., Wirtz T., Sellei R., Schmidt-Rohlfing B., Paar O., et al. Structural, mechanical and in vitro characterization of individually structured Ti-6Al-4V produced by direct laser forming. Biomaterials 2006, 27:955-963.
16. Li X., Wang C.T., Zhang W.G., Li Y.C. Properties of a porous Ti-6Al-4V implant with a low stiffness for biomedical application. Proc Inst Mech Eng H 2009, 223:173-178.
17. Hou C.J., Liu J.L., Li X., Bi L.J. Insulin promotes bone formation in augmented maxillary sinus in diabetic rabbits. Int J Oral Maxillofac Surg 2012, 41:400-407.
18. Cao X.Y., Yin M.Z., Zhang L.N., Li S.P., Cao Y. Establishment of a new model for culturing rabbit osteoblasts in vitro. Biomed Mater 2006, 1:L16-L19.
19. Irrcher I., Ljubicic V., Hood D.A. Interactions between ROS and AMP kinase activity in the regulation of PGC-1alpha transcription in skeletal muscle cells. Am J Physiol Cell Physiol 2009, 296:C116-C123.
20. Zhao L., Mei S., Chu P.K., Zhang Y., Wu Z. The influence of hierarchical hybrid micro/nano-textured titanium surface with titania nanotubes on osteoblast functions. Biomaterials 2010, 31:5072-5082.
21. Puntel R.L., Roos D.H., Grotto D., Garcia S.C., Nogueira C.W., Rocha J.B. Antioxidant properties of Krebs cycle intermediates against malonate pro-oxidant activity in vitro: a comparative study using the colorimetric method and HPLC analysis to determine malondialdehyde in rat brain homogenates. Life Sci 2007, 81:51-62.
22. Galli C., Piemontese M., Lumetti S., Ravanetti F., Macaluso G.M., Passeri G. Actin cytoskeleton controls activation of Wnt/beta-catenin signaling in mesenchymal cells on implant surfaces with different topographies. Acta Biomater 2012, 8:2963-2968.
23. Vlacic-Zischke J., Hamlet S.M., Friis T., Tonetti M.S., Ivanovski S. The influence of surface microroughness and hydrophilicity of titanium on the up-regulation of TGFbeta/BMP signalling in osteoblasts. Biomaterials 2011, 32:665-671.
24. Wang W., Zhao L., Ma Q., Wang Q., Chu P.K., Zhang Y. The role of the Wnt/beta-catenin pathway in the effect of implant topography on MG63 differentiation. Biomaterials 2012, 33:7993-8002.
25. Dabrowski B., Swieszkowski W., Godlinski D., Kurzydlowski K.J. Highly porous titanium scaffolds for orthopaedic applications. J Biomed Mater Res B Appl Biomater 2010, 95:53-61.
26. Mellado-Valero A., Ferrer Garcia J.C., Herrera Ballester A., Labaig Rueda C. Effects of diabetes on the osseointegration of dental implants. Med Oral Patol Oral Cir Bucal 2007, 12:E38-E43.
27. Lerner U.H. Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. J Dent Res 2006, 85:596-607.
28. Colombo J.S., Balani D., Sloan A.J., Crean S.J., Okazaki J., Waddington R.J. Delayed osteoblast differentiation and altered inflammatory response around implants placed in incisor sockets of type 2 diabetic rats. Clin Oral Implant Res 2011, 22:578-586.
29. von Wilmowsky C., Stockmann P., Harsch I., Amann K., Metzler P., Lutz R., et al. Diabetes mellitus negatively affects peri-implant bone formation in the diabetic domestic pig. J Clin Periodontol 2011, 38:771-779.
30. Guan C.C., Yan M., Jiang X.Q., Zhang P., Zhang X.L., Li J., et al. Sonic hedgehog alleviates the inhibitory effects of high glucose on the osteoblastic differentiation of bone marrow stromal cells. Bone 2009, 45:1146-1152.
31. Verhaeghe J., Thomsen J.S., van Bree R., van Herck E., Bouillon R., Mosekilde L. Effects of exercise and disuse on bone remodeling, bone mass, and biomechanical competence in spontaneously diabetic female rats. Bone 2000, 27:249-256.
32. Gopalakrishnan V., Arunakaran J., Aruldhas M.M., Srinivasan N. Effects of streptozotocin-induced diabetes mellitus on some bone turnover markers in the vertebrae of ovary-intact and ovariectomized adult rats. Biochem Cell Biol 2006, 84:728-736.
33. Wittrant Y., Gorin Y., Woodruff K., Horn D., Abboud H.E., Mohan S., et al. High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis. Bone 2008, 42:1122-1130.
34. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
35. Hamada Y., Fujii H., Fukagawa M. Role of oxidative stress in diabetic bone disorder. Bone 2009, 45:S35-S38.
36. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790.
37. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1995, 46:223-234.
38. Cnop M., Welsh N., Jonas J.C., Jorns A., Lenzen S., Eizirik D.L. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005, 54:S97-S107.
39. Altenhofer S., Kleikers P.W., Radermacher K.A., Scheurer P., Rob Hermans J.J., Schiffers P., et al. The NOX toolbox: validating the role of NADPH oxidases in physiology and disease. Cell Mol Life Sci 2012, 69:2327-2343.
40. Chen J.R., Lazarenko O.P., Shankar K., Blackburn M.L., Lumpkin C.K., Badger T.M., et al. Inhibition of NADPH oxidases prevents chronic ethanol-induced bone loss in female rats. J Pharmacol Exp Ther 2011, 336:734-742.
41. Huang T.T., Carlson E.J., Raineri I., Gillespie A.M., Kozy H., Epstein C.J. The use of transgenic and mutant mice to study oxygen free radical metabolism. Ann N Y Acad Sci 1999, 893:95-112.
42. Fini M., Giavaresi G., Torricelli P., Borsari V., Giardino R., Nicolini A., et al. Osteoporosis and biomaterial osteointegration. Biomed Pharmacother 2004, 58:487-493.
43. Ma Y., Wang H. PI3K/Akt/FoxO: a novel participant in signal transduction in bone cells under mechanical stimulation. Cell Biol Int 2012, 36:923-926.
44. Mody N., Parhami F., Sarafian T.A., Demer L.L. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 2001, 31:509-519.
45. Sanchez-Rodriguez M.A., Ruiz-Ramos M., Correa-Munoz E., Mendoza-Nunez V.M. Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes. BMC Musculoskelet Disord 2007, 8:124.
46. Chen R.M., Wu G.J., Chang H.C., Chen J.T., Chen T.F., Lin Y.L., et al. 2,6-Diisopropylphenol protects osteoblasts from oxidative stress-induced apoptosis through suppression of caspase-3 activation. Ann N Y Acad Sci 2005, 1042:448-459.
47. Fatokun A.A., Stone T.W., Smith R.A. Hydrogen peroxide-induced oxidative stress in MC3T3-E1 cells: the effects of glutamate and protection by purines. Bone 2006, 39:542-551.
48. Feng Y.F., Wang L., Li X., Ma Z.S., Zhang Y., Zhang Z.Y., et al. Influence of architecture of beta-tricalcium phosphate scaffolds on biological performance in repairing Segmental bone defects. PLoS One 2012, 7:e49955.
49. Ghanaati S., Barbeck M., Orth C., Willershausen I., Thimm B.W., Hoffmann C., et al. Influence of beta-tricalcium phosphate granule size and morphology on tissue reaction in vivo. Acta Biomater 2010, 6:4476-4487.
50. Manolagas S.C. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev 2010, 31:266-300.
51. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39:44-84.